| Rochelle Gibb, MA, CCC-SLP | |
|
1000 Herrontown Rd, Princeton, NJ 08540-7716 | |
| (732) 617-1500 | |
| Not Available |
| Full Name | Rochelle Gibb |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1000 Herrontown Rd, Princeton, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447914536 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00986800 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rochelle Gibb, MA, CCC-SLP 4 Ivy Way, Dayton, NJ 08810-1420 Ph: () - | Rochelle Gibb, MA, CCC-SLP 1000 Herrontown Rd, Princeton, NJ 08540-7716 Ph: (732) 617-1500 |
News Archive
Anulex Technologies, Inc., a privately held medical device manufacturer focusing on soft tissue Preservation & Anular Repair products, announced the first closing of its fifth round of private equity financing which will total a minimum of $20 million. The Series E round was led by a new unnamed strategic investor with participation from existing investors Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.
Amid concern that recipients of certain blood transfusions may risk infection with a deadly protein responsible for the human form of mad cow disease, researchers in Canada now report development of a special filter that quickly and effectively removes the protein from blood.
Researchers from Queen Mary, University of London and the University of Surrey have found a protein inside blood vessels with an ability to protect the body from substances which cause cardiovascular disease.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
› Verified 2 days ago
Stuttering Institute Of Princeton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 194 N Harrison St, Princeton, NJ 08540 Phone: 609-924-2809 Fax: 609-924-7995 | |
Ms. Heather Cronk, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 70 Forest Ave, Princeton, NJ 08540 Phone: 908-331-1522 | |
Ms. Diana Rose Becker, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 256 Bunn Dr Ste A, Princeton, NJ 08540 Phone: 609-430-9200 Fax: 609-430-9202 | |
Stephanie Slavitt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 522 Executive Dr, Princeton, NJ 08540 Phone: 609-987-2672 | |
Ms. Constance Wieler, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Saint Clair Ct, Princeton, NJ 08540 Phone: 609-688-0200 Fax: 609-688-0200 | |
Maria Ciufo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53 Bayard Ln, Princeton, NJ 08540 Phone: 609-924-8120 | |
Maria Oakes, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6 Taylor Rd, Princeton, NJ 08540 Phone: 732-329-1872 |